Product: HRT2 Antibody
Catalog: AF9092
Description: Rabbit polyclonal antibody to HRT2
Application: WB IF/ICC
Reactivity: Human, Mouse, Rat
Prediction: Pig, Zebrafish, Bovine, Horse, Sheep, Rabbit, Dog, Chicken, Xenopus
Mol.Wt.: 36kDa; 36kD(Calculated).
Uniprot: Q9UBP5
RRID: AB_2843283

View similar products>>

   Size Price Inventory
 100ul $280 In stock
 200ul $350 In stock

Lead Time: Same day delivery

For pricing and ordering contact:
Local distributors

Product Info

Source:
Rabbit
Application:
WB 1:1000, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

Reactivity:
Human,Mouse,Rat
Prediction:
Pig(100%), Zebrafish(100%), Bovine(100%), Horse(100%), Sheep(100%), Rabbit(100%), Dog(100%), Chicken(100%), Xenopus(100%)
Clonality:
Polyclonal
Specificity:
HRT2 Antibody detects endogenous levels of total HRT2.
RRID:
AB_2843283
Cite Format: Affinity Biosciences Cat# AF9092, RRID:AB_2843283.
Conjugate:
Unconjugated.
Purification:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
Storage:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
Alias:

Fold/Unfold

bHLHb32; Cardiovascular helix loop helix factor 1; Cardiovascular helix-loop-helix factor 1; CHF1; Class B basic helix-loop-helix protein 32; GRIDLOCK; GRL; Hairy and enhancer of split related 2; Hairy and enhancer of split-related protein 2; Hairy related transcription factor 2; Hairy-related transcription factor 2; Hairy/enhancer-of-split related with YRPW motif protein 2; hCHF1; HERP; HERP1; HES related repressor protein 1; HES-related repressor protein 2; HESR-2; HESR2; hey2; HEY2_HUMAN; hHRT2; HRT-2; HRT2; MGC10720; Protein gridlock homolog;

Immunogens

Immunogen:
Uniprot:
Gene(ID):
Sequence:
MKRPCEETTSESDMDETIDVGSENNYSGQSTSSVIRLNSPTTTSQIMARKKRRGIIEKRRRDRINNSLSELRRLVPTAFEKQGSAKLEKAEILQMTVDHLKMLQATGGKGYFDAHALAMDFMSIGFRECLTEVARYLSSVEGLDSSDPLRVRLVSHLSTCATQREAAAMTSSMAHHHHPLHPHHWAAAFHHLPAALLQPNGLHASESTPCRLSTTSEVPPAHGSALLTATFAHADSALRMPSTGSVAPCVPPLSTSLLSLSATVHAAAAAATAAAHSFPLSFAGAFPMLPPNAAAAVAAATAISPPLSVSATSSPQQTSSGTNNKPYRPWGTEVGAF

Predictions

Predictions:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Pig
100
Horse
100
Bovine
100
Sheep
100
Dog
100
Xenopus
100
Zebrafish
100
Chicken
100
Rabbit
100
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

PTMs - Q9UBP5 As Substrate

Site PTM Type Enzyme
S39 Phosphorylation
K58 Acetylation
T96 Phosphorylation
T131 Phosphorylation
S138 Phosphorylation
S139 Phosphorylation
S145 Phosphorylation
S205 Phosphorylation
S207 Phosphorylation

Research Backgrounds

Function:

Downstream effector of Notch signaling which may be required for cardiovascular development. Transcriptional repressor which binds preferentially to the canonical E box sequence 5'-CACGTG-3'. Represses transcription by the cardiac transcriptional activators GATA4 and GATA6.

Subcellular Location:

Nucleus.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
Subunit Structure:

May self-associate (By similarity). Interacts with GATA4, HES1 and HEYL (By similarity). Interacts with HDAC1, NCOR1 and SIN3A (By similarity). Interacts with ARNT and GATA6.

Family&Domains:

Belongs to the HEY family.

Research Fields

· Human Diseases > Infectious diseases: Viral > Human papillomavirus infection.

· Human Diseases > Cancers: Overview > Pathways in cancer.   (View pathway)

· Human Diseases > Cancers: Specific types > Breast cancer.   (View pathway)

References

1). Medical Prospect of Melatonin in the Intervertebral Disc Degeneration through Inhibiting M1-Type Macrophage Polarization via SIRT1/Notch Signaling Pathway. Biomedicines, 2023 (PubMed: 37371708) [IF=4.7]

Application: WB    Species: Mouse    Sample: RAW 264.7 Mφs

Figure 5 Regulation of SIRT1/Notch signal pathway contributes to the effect of MLT on inhibiting M1-type Mφ polarization. RAW 264.7 Mφs were exposed to LPS for 6 h and followed by MLT treatment for 24 h, then treated with SIRT1 agonists (SRT1720) or inhibitors (EX527) for another 6 h and followed by different analysis. (A) Reduction of the ratio of M1-type Mφs while enhancement of the ratio of M2-type Mφs after the treatment with MLT, aggravated in combination with SRT1720, and reversed in the presence of EX527, was determined by flow cytometry assay. (B) The relative mRNA levels of M1-type Mφ genes (IL-6 and TNF-α) and M2-type Mφ genes (IL-4 and IL-10) were measured by RT-qPCR analyses (n = 3). The levels of IL-6 and TNF-α mRNA were reduced in the presence of MLT treatment, downregulated in combination with SRT1720, and upregulated in the presence of EX527. (C,D) The relative protein levels of SIRT1 and NICD in Mφs were measured by Western blot analyses (n = 3). (C) Western blotting showed the upregulation of the SIRT1 protein with the downregulation of the NICD protein, aggravated in combination with SRT1720, and reversed in the presence of EX527. (D) Quantitative analysis showed the increased level of the SIRT1 protein, with the reduced level of the NICD protein after the treatment with MLT, aggravated in combination with SRT1720, and reversed in the presence of EX527. (E) IP with the anti-NICD antibody was used to verify the interaction between SIRT1 and NICD. The interaction between SIRT1 and NICD in the LPS + MLT-treated Mφs was markedly increased compared with that in the LPS-treated Mφs. Moreover, treatment with SRT1720 further aggravated this interaction, while treatment with EX527 ameliorated the interaction. (F) The relative mRNA levels of downstream target genes of the SIRT1/Notch signaling pathway were measured by RT-qPCR analyses in Mφs (n = 3). The levels of Notch1, HES1, HEY2 and NRARP mRNA were downregulated after the treatment with MLT, downregulated in combination with SRT1720, and upregulated in the presence of EX527. (G,H) The relative protein levels of downstream factors of the SIRT1/Notch signaling pathway were measured by Western blot analyses in Mφs (n = 3). (G) Western blotting showed the downregulation of downstream factors protein of the SIRT1/Notch signaling pathway in Mφs. (H) Quantitative analysis showed the reduced levels of Notch1, HES1, HEY2 and NRARP protein after the treatment with MLT, downregulated in combination with SRT1720, and upregulated in the presence of EX527. Data are expressed as mean ± standard deviation. The two groups among the five groups are compared by using an independent t-test.

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.